Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Inna, Naumov"'
Autor:
Ilan Aroch, Sarah Kraus, Inna Naumov, Ehud Ron, Shiran Shapira, Dina Kazanov, Nis Giladi, Alex Litvak, Shahar Lev-Ari, Aharon Hallak, Iris Dotan, Baruch Shpitz, Nadir Arber
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 3 (2010)
Objectives: Coltect is a novel dietary supplement containing curcumin, green tea and selenomethionine. Previous reports have suggested that these agents can prevent colorectal cancer (CRC). The present study examined the chemopreventive effect of Col
Externí odkaz:
https://doaj.org/article/da1e0f30c9b84983a99429369d7b777c
Autor:
Menachem Moshkowitz, Einat Shmueli, Sarah Kraus, Lior Galazan, Nadir Arber, Inna Naumov, Ravit Geva, Dina Kazanov, Erwin Santo, Aharon Hallack, Shiran Shapira
Publikováno v:
Disease Markers
Disease Markers, Vol 2015 (2015)
Disease Markers, Vol 2015 (2015)
CD24 is expressed in 90% of colorectal adenomas and adenocarcinomas. Colorectal cancer (CRC) can be mostly prevented but average risk population screening by stool testing or colonoscopy faces many hurdles. Blood testing is clinically needed. We aime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d0331e917f532c17c31ca962a779c6
https://doi.org/10.1155/2015/916098
https://doi.org/10.1155/2015/916098
Autor:
Dina Kazanov, Sarah Kraus, Doran Avivi, Nadir Arber, Inna Naumov, Shiran Shapira, Alona Zilberberg, Rina Rosin-Arbesfeld
Publikováno v:
International Journal of Cancer. 135:1048-1059
Increased expression of CD24 is seen in a large variety of solid tumors, including up to 90% of gastrointestinal (GI) tumors. Stable derivatives of SW480 colorectal cancer (CRC) cells that overexpress CD24 proliferate faster, and increase cell motili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f1e89227a3a2d1b988bd4b913e443d8
https://doi.org/10.1002/ijc.28762
https://doi.org/10.1002/ijc.28762
Autor:
Mati Ormianer, Olivia Rosenfeld, Sarah Kraus, Ariel J. Jaffa, Inna Naumov, Fanny Sperber, Arye Blachar, Ilan Aroch, Diana Kazanov, Eliezer Liberman, Tal Sella, Eyal Gur, Miki Bloch, Vadim Reiser, Amira Gat-Charlap, Lior Galazan, Nadir Arber, Shlomi Kleinman, Roy Inbar, Ben Boursi, Menachem Moshkowitz, Ehud Miller, Nicola J. Mabjeesh
Publikováno v:
European Journal of Internal Medicine. 24:245-249
Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality.We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f0efd780a0cc182accab6d7aa89925a
https://doi.org/10.1016/j.ejim.2012.12.012
https://doi.org/10.1016/j.ejim.2012.12.012
Autor:
Sarah Kraus, Inna Naumov, Victoria Lisiansky, Nadir Arber, Alex Starr, Shiran Shapira, Dina Kazanov
Publikováno v:
Cancer Gene Therapy. 19:862-869
Ras mutations are present in ∼95% of pancreatic cancer (PC) cases leading to increased proliferation and apoptosis resistance. The aim of this study is to selectively kill Ras-transformed cells by overexpressing the pro-apoptotic protein, p53 upreg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c986d3e44bb35c0ece0596f5025e2d
https://doi.org/10.1038/cgt.2012.73
https://doi.org/10.1038/cgt.2012.73
Autor:
Ilan Aroch, Dina Kazanov, Sarah Kraus, Nadir Arber, Victoria Lisiansky, Inna Naumov, Shiran Shapira, Alex Starr
Publikováno v:
Experimental Cell Research. 318:160-168
Background Functional activation of oncogenic K-Ras signaling pathway plays an important role in the early events of colorectal carcinogenesis (CRC). K-Ras proto-oncogene is involved in 35–40% of CRC cases. Mutations in the Ras gene trigger the tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b043750e8623618de69f948e49540cd
https://doi.org/10.1016/j.yexcr.2011.09.015
https://doi.org/10.1016/j.yexcr.2011.09.015
Autor:
Marta Jeison, Smadar Avigad, Gili Halevy Berco, Isaac Meller, Isaac Yaniv, Yehuda Kollender, Inna Naumov, Batia Stark, Anat Ohali, Shifra Ash, Jacques Mardoukh, Ian J. Cohen, Josephine Issakov
Publikováno v:
Clinical Cancer Research. 13:5777-5783
Purpose: Despite advances in therapy, >50% of patients with Ewing sarcoma will relapse. The current prognostic factors are not optimal for risk prediction. Studies have shown that telomere length could predict outcome in different malignancies. Our a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfaaba2c7722cd50fcb35829ac84777
https://doi.org/10.1158/1078-0432.ccr-07-0308
https://doi.org/10.1158/1078-0432.ccr-07-0308
Autor:
Sarah, Kraus, Inna, Naumov, Shiran, Shapira, Dina, Kazanov, Ilan, Aroch, Arnon, Afek, Oded, Eisenberg, Jacob, George, Nadir, Arber, Ariel, Finkelstein
Publikováno v:
The Israel Medical Association journal : IMAJ. 16(4)
Atherosclerosis is a complex vascular inflammatory disease. In the last decade it was suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) and in particular inhibition of cyclooxygenase (COX)-2 are associated with an increase in cardiovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2891dee01199b63749b2f2ff7473d54c
https://pubmed.ncbi.nlm.nih.gov/24834760
https://pubmed.ncbi.nlm.nih.gov/24834760
Autor:
Natalio Garbi, Louis Boon, Safwan Joumaa, Gerhard Moldenhauer, Kai Doberstein, Peter Altevogt, Inna Naumov, Alexei V. Salnikov, Niko P. Bretz, Nadir Arber, Volker Kloess
Publikováno v:
Immunology letters. 161(1)
CD24 is an extensively glycosylated membrane protein that is linked to the membrane via a glycosyl-phosphatidylinositol (GPI)-anchor. In mice, CD24 is expressed by hematopoietic and non-hematopoietic cells. CD24-/- mice do not have gross immunologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac39fb490b65605bd7766cb2b8e0bf26
https://pubmed.ncbi.nlm.nih.gov/24956310
https://pubmed.ncbi.nlm.nih.gov/24956310
Autor:
Karen W. Makar, Dominique Scherer, Anna E. Coghill, Cornelia M. Ulrich, Biljana Gigic, Jana Kotzmann, Elizabeth M. Poole, David Duggan, Inna Naumov, Dina Kazanov, Sarah Kraus, Simone Hummler, Nadir Arber, Lior Galazan, Adetunji T. Toriola
Publikováno v:
Pharmacogenetics and genomics. 23(8)
Chemoprevention trials have shown that celecoxib reduces adenoma recurrence but can cause cardiovascular toxicity. In this pilot study, we evaluated associations between genetic variation in several candidate pathways (e.g. prostaglandin synthesis) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c96d348d41924a58eb65f295479265
https://pubmed.ncbi.nlm.nih.gov/23778325
https://pubmed.ncbi.nlm.nih.gov/23778325